XML 39 R76.htm IDEA: XBRL DOCUMENT v3.3.0.814
Income Taxes (Narrative) (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Dec. 26, 2014
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Income Taxes [Line Items]        
Operating loss carryforward   $ 7.0 $ 221.3  
Tax credit carryforward   16.3 8.6  
Tax Credit Carryforward Utilization   14.3    
Income Tax Holiday, Aggregate Dollar Amount   5.1 0.3  
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount [1],[2]   (138.6) (10.6) $ 3.3
Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount   21.5 $ 32.1 $ 10.0
Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent     21.00% 23.00%
Increase (Decrease) Tax Benefit, Jurisdiction Rate Difference   128.0 $ 13.9  
Increase (Decrease) Tax Expense (Benefit), Change in Operating Income   35.0 10.8  
Increase (Decrease) Tax Expense (Benefit) Due to Amortization of Intangible Assets   22.5 14.0  
Increase (Decrease) Foreign Tax Expense (Benefit) Due To Acquisitions   31.8    
Increase (Decrease) Tax Expense (Benefit), Other   62.2 38.7  
Unrecognized tax benefits that would require cash remittance if not sustained   89.2 82.0 $ 100.1
Unrecognized tax benefits, which if favorably settled would benefit the effective tax rate   87.4 82.0 96.3
Interest expense on unrecognized tax benefits   5.7 7.0 2.4
Released tax interest   9.3    
Interest accrued on unrecognized tax benefits   41.7 45.1 $ 62.1
Decrease in Unrecognized Tax Benefits is Reasonably Possible   17.5    
Income tax penalties and interest accrued that would impact effective tax rate, upper bound of change   8.8    
Tax payments associated with non-current deferred intercompany transactions   52.2 14.8  
Tax payments associate with current deferred intercompany transactions   8.7 0.6  
Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority   81.3    
Deferred income taxes   142.7 152.3  
Deferred income taxes (non-current liability)   3,132.4 2,399.6  
Increase (decrease), deferred tax liability   44.0    
Increase (Decrease), Deferred Tax Liability Due to Amortization of Intangible Assets   54.3    
Deferred tax assets, tax credit carryforwards   163.3 93.8  
Deferred tax assets, valuation allowance   233.0 76.9  
Increase (decrease) deferred tax liability due to installment sale   1,465.3 93.6  
Deferred tax liabilities, intangible assets   1,550.7 2,177.9  
Deferred Tax Liabilities, Property, Plant and Equipment   140.1 121.6  
Deferred Tax Asset, Financing Payment   20.2 32.0  
Tax credit carryforwards, not subject to expiration   3.1    
Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Undistributed Earnings of Foreign Subsidiaries   369.0    
Deferred Tax Liabilities, Undistributed Foreign Earnings   0.7    
Undistributed Earnings   13.4    
Ikaria        
Income Taxes [Line Items]        
Operating loss carryforward   4.8    
Tax credit carryforward   7.2    
Deferred Tax Liabilities, Net   623.6    
Increase (decrease), deferred tax liability   596.9    
Deferred tax liabilities, intangible assets   620.2    
Deferred Tax Liabilities, Property, Plant and Equipment   17.5    
Deferred Tax Assets, Tax Credit Carryforwards, Foreign   21.7    
Deferred Tax Asset, Financing Payment   13.1    
Deferred Tax Assets, Operating Loss Carryforwards, Foreign   4.9    
Therakos        
Income Taxes [Line Items]        
Increase (decrease), deferred tax liability   324.3    
Deferred tax liabilities, intangible assets   334.1    
Deferred Tax Assets, Operating Loss Carryforwards, Foreign   13.5    
Increase (Decrease), Deferred Tax Liability, Net   324.3    
Cadence Pharmaceuticals, Inc.        
Income Taxes [Line Items]        
Operating loss carryforward     187.8  
Increase (decrease) deferred tax asset resulting from installment sale transaction   105.4    
Questcor Pharmaceuticals, Inc.        
Income Taxes [Line Items]        
Increase (Decrease) In Prepaid Taxes, Installment Sale $ 1.9      
Income Taxes Receivable     60.0  
Increase (decrease) deferred tax liability due to installment sale 1,515.9      
Increase (Decrease) Deferred Tax Charge, Installment Sale 25.3      
Increase (Decrease) in Deferred Tax Liability, Intangible Assets $ 1,488.7      
Internal Revenue Service (IRS)        
Income Taxes [Line Items]        
Advance payment in connection with proposed settlements of certain tax matters   8.9    
Advance payment in connection with proposed settlement of certain tax matters, tax payment   7.4    
Advance payment in connection with proposed settlement of certain tax matters, interest payment   $ 1.5    
Internal Revenue Service (IRS) | Covidien        
Income Taxes [Line Items]        
Advance payment in connection with proposed settlements of certain tax matters     35.9  
Advance payment in connection with proposed settlement of certain tax matters, tax payment     27.3  
Advance payment in connection with proposed settlement of certain tax matters, interest payment     $ 8.6  
U.S. - Federal and State        
Income Taxes [Line Items]        
Tax years that remain subject to examination   1996    
Operating loss carryforwards, subject to expiration   $ 19.6    
IRELAND        
Income Taxes [Line Items]        
Tax years that remain subject to examination   2009    
Foreign Tax Authority        
Income Taxes [Line Items]        
Operating loss carryforwards   $ 126.0    
Operating loss carryforwards, not subject to expiration   91.4    
Operating loss carryforwards, subject to expiration   34.6    
Discontinued Operations, Held-for-sale        
Income Taxes [Line Items]        
Deferred Tax Liabilities, Undistributed Foreign Earnings   6.5    
Undistributed Earnings   $ 41.3    
[1] Fiscal year 2013 includes impact of items relating to entities retained by Covidien in connection with the Separation.
[2] Includes the impact of certain recurring valuation allowances for Domestic and International jurisdictions.